Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Ottawa
$105,000.00
The relationship between disease progression and chemoresistance mediated by plasma gelsolin in epithelial ovarian cancer
FY 2022-23
Summary
Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer due to diagnosis in advanced-stage disease and resistance to treatment. Previous work has shown that plasma gelsolin (pGSN) is a protein that plays an important role in EOC chemoresistance. Interestingly, chemoresistance is a feature of epithelial mesenchymal transition (EMT), a process that contributes to disease progression and metastasis. For this reason, we believe that pGSN is promoting both resistance to therapy and disease progression. In this work, we plan to study whether pGSN promotes EMT and if the commonly seen chemoresistance in EOC is associated with EMT. We will first investigate this in vitro with ovarian cancer cells, and will then confirm our findings in human EOC tumour samples. With these findings, we hope to better understand some of the processes that contribute to high mortality in EOC patients and to identify treatment strategies to improve patient outcomes.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
476288
Name
Gerber Emma
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The relationship between disease progression and chemoresistance mediated by plasma gelsolin in epithelial ovarian cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Biomarkers; Cell Signaling; Chemoresistance; Epithelial Mesenchymal Transition; Epithelial Ovarian Cancer; Patient Survival; Plasma Gelsolin; Small Extracellular Vesicles; Tumour Microenvironment
Abstract
Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer due to diagnosis in advanced-stage disease and resistance to treatment. Previous work has shown that plasma gelsolin (pGSN) is a protein that plays an important role in EOC chemoresistance. Interestingly, chemoresistance is a feature of epithelial mesenchymal transition (EMT), a process that contributes to disease progression and metastasis. For this reason, we believe that pGSN is promoting both resistance to therapy and disease progression. In this work, we plan to study whether pGSN promotes EMT and if the commonly seen chemoresistance in EOC is associated with EMT. We will first investigate this in vitro with ovarian cancer cells, and will then confirm our findings in human EOC tumour samples. With these findings, we hope to better understand some of the processes that contribute to high mortality in EOC patients and to identify treatment strategies to improve patient outcomes.
Competitiondate
202211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Gerber, Emma
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~